Page last updated: 2024-10-25

clotrimazole and Hypopigmentation

clotrimazole has been researched along with Hypopigmentation in 1 studies

Hypopigmentation: A condition caused by a deficiency or a loss of melanin pigmentation in the epidermis, also known as hypomelanosis. Hypopigmentation can be localized or generalized, and may result from genetic defects, trauma, inflammation, or infections.

Research Excerpts

ExcerptRelevanceReference
"To evaluate the efficacy of topical tacrolimus on pityriasis versicolor."9.24Comparative efficacy of topical application of tacrolimus and clotrimazole in the treatment of pityriasis versicolor: A single blind, randomised clinical trial. ( Bagheri, Z; Pakshir, K; Sadat, MS; Sepaskhah, M, 2017)
"To evaluate the efficacy of topical tacrolimus on pityriasis versicolor."5.24Comparative efficacy of topical application of tacrolimus and clotrimazole in the treatment of pityriasis versicolor: A single blind, randomised clinical trial. ( Bagheri, Z; Pakshir, K; Sadat, MS; Sepaskhah, M, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sepaskhah, M1
Sadat, MS1
Pakshir, K1
Bagheri, Z1

Trials

1 trial available for clotrimazole and Hypopigmentation

ArticleYear
Comparative efficacy of topical application of tacrolimus and clotrimazole in the treatment of pityriasis versicolor: A single blind, randomised clinical trial.
    Mycoses, 2017, Volume: 60, Issue:5

    Topics: Adult; Anti-Infective Agents, Local; Antifungal Agents; Clotrimazole; Drug Administration Schedule;

2017